Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance Deanna D. Hill; Jennifer R. Kramer; Kassie R. Chaffin; T. Christopher Mast; Michael N. Robertson; Fasiha Kanwal; Barbara A. Haber;

Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies Jui-Hsiang Hung; Chiao-Feng Teng; Hsu-chin Hung; Yi-Lin Chen; Pin-Jun Chen; Chung-Liang Ho; Cheng-Hsiang Chuang; Wenya Huang;

Spending on nucleos(t)ide analogues for hepatitis B in medicaid beneficiaries: 2012-2021 Stephen E. Congly; Mayur Brahmania; Carla S. Coffin;